Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Proponents often stress the opportunity for meaningful therapeutic gains, particularly in ailments where conventional therapies have proven limited. However, crucially important to evaluate the considerable financial expenditure associated with CPI stem c